Generally, homeostatic maintenance of p62 expression levels in both tumor and stroma may decide the final outcomes of tumor initiation and progression through complex regulatory network involving mTORC1/Myc, NRF2 and NF-κB signaling pathways [15, 16]. This evidence concerns the gene SQSTM1 and neoplasm.